Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Glaxosmithkline Plc (NY: GSK )

38.36 USD +0.58 (+1.54%)
Official Closing Price Updated: 7:56 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Glaxosmithkline Plc

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More
Biopharma stocks advanced yet again in the week ended Jan. 22, with the change of guard at the White House generating broader market ... 
Tags TARO RMD Earnings
From Benzinga
The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags LH PROF MRUS
From Benzinga
Pfizer, GSK-Backed ViiV First To Get FDA Approval For HIV Shots: What You Need To Know
In a first, a monthly injectable HIV drug made by a GlaxoSmithKline plc (NYSE: GSK)- and Pfizer Inc (NYSE: PFE)-owned company has ... 
Tags Market News HIV Biotech
From Benzinga
Investors Celebrate
Pfizer's good news is that its vaccine protects against virus mutations. 
Tags ETFs Stocks / Equities
From Blogs - TalkMarkets
Novartis and GSK Announce Collaboration to Support Scientific Research Into Genetic Diversity in Africa
Tags Responsible Business & Employee Engagement africa Innovation & Technology
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Three Governments In Trouble
Three countries are now in an interregnum: the USA, Italy, and The Netherlands. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Benzinga's Top Ratings Upgrades, Downgrades For January 15, 2021
Upgrades For Stifel Financial Corp (NYSE:SF), Wells Fargo upgraded the previous rating of Underweight to Equal-Weight. ... 
Tags SGEN EVBG PINC
From Benzinga
Learning From Stock Market Losers
Rule Breaker Investing: David's Biggest Losers Volume 6 
Tags TCEHY AAPL NFLX
From Motley Fool
J.P.Morgan Healthcare Conference 2021: Current Portfolio Positions #1
The Conference boosted many stocks as you might expect in a bull market for biotech. We reviewed rather quickly some of the presentations from the JPMorgan Healthcare Conference and will comment on... 
Tags Stocks / Equities ETFs Healthcare
From Blogs - TalkMarkets
Pharma And Religion
Tuesday saw Wall Street anxious to avoid a second down day in a row despite politics and health issues. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Why Vir Biotechnology Stock Vaulted Higher Today
The biotech announced updates about collaborations with two big partners. 
Tags VIR GILD Market News
From Motley Fool
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TXG SYNH AZN
From Benzinga
Vir Biotechnology and GSK Announce NHS-Supported AGILE Study to Evaluate VIR-7832 in the Early Treatment of COVID-19
From GlobeNewswire News Releases
Good News, Bad News Day
Today the stock market woke up to the risks both political and economic facing the Land of the Free and the Home of the Brave after reflecting over the weekend. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines 
From Business Wire News Releases
Eligo inks deal with GSK potentially worth up to $224M
Eligo Bioscience SA (Eligo) today announced that it has entered into a research and option agreement with GlaxoSmithKline (NYSE: GSK) aimed at advancing Eligobiotics® for the treatment or prevention of... 
From PR Newswire
AstraZeneca has scope to increase dividend by 25%, key broker says, as broader FTSE 100 edges lower
Anglo-Swedish pharmaceutical AstraZeneca has scope to increase its dividend by 25%, a key broker said on Friday. 
Tags UK:ULVR UK:GSK UK:HSBA
From MarketWatch
AstraZeneca has scope to increase dividend by 25%, key broker says, as broader FTSE 100 edges lower
Anglo-Swedish pharmaceutical AstraZeneca has scope to increase its dividend by 25%, a key broker said on Friday. 
Tags UK:ULVR UK:GSK UK:AZN
From MarketWatch
Movements In Stocks After Georgia Votes
Apart from the votes, new data on jobless levels also frightened the market. Private payrolls fell to 123,000 in December, more than double the forecast by economists, as larger companies suspended... 
Tags Stocks / Equities Technology Bonds
From Blogs - TalkMarkets
Is Pfizer Stock a Buy?
The company is poised to begin delivering on its promise of growth and innovation. 
Tags VTRS Market News GSK
From Motley Fool
Market Briefing For Tuesday, Jan. 5
A stiff hangover greeted the big-cap market to start the year, while relative stability or rebounds were seen in a number of small-cap stocks that struggled late in 2020. Reinforcing my suspicion about... 
Tags Stocks / Equities Technology Capital & Industrial Goods
From Blogs - TalkMarkets
Welcome To 2021
US stock markets tried and failed to start the year with a new high 
Tags Stocks / Equities
From Blogs - TalkMarkets
5 Big ETF Stories Of 2020 Worth Watching In 2021
After slipping into a bear market in late March, Wall Street made an astounding rebound with major indices soaring to historic highs. This is especially true against the backdrop of super-easy monetary... 
Tags Stocks / Equities ETFs
From Blogs - TalkMarkets
Pfizer, GSK & Others Quietly Hike Prices On 100s Of Drugs
With drugmakers' dedicating themselves to defeating COVID-19 the industry is insisting that profits must be made up elsewhere. So prices on some 300 drugs will rise, with formal announcements expected... 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Poor Technology
Today the stock market was supposed to recuperate after falling yesterday. 
Tags Stocks / Equities
From Blogs - TalkMarkets
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags QLGN BBIO ICPT
From Benzinga
Is Pfizer Stock A Buy On A New U.S. Supply Deal For Covid Vaccine?
U.S. officials inked a deal for 100 million more doses of Pfizer's coronavirus vaccine. That brings the total number of vaccine doses up to 200 million. So, is Pfizer stock a buy now? 
From Investor's Business Daily
Week In Review: How Trump's Policies Moved Stocks -Saturday, Dec. 26
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump and his administration with this weekly... 
Tags Pharma/Biotech Stocks / Equities Capital & Industrial Goods
From Blogs - TalkMarkets
Christmas Eve Market
The British and the EU did manage to craft a Brexit deal and sterling rose a tad under 0.8% to $1.36, a 2020 high. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Stock Market Risks
Pfizer is supplying another 100 milion doses to the US and will deliver vaccines to Mexico by Dec. 23. 
Tags Stocks / Equities
From Blogs - TalkMarkets
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.